Pioneer factors in development and cancer

• Main Authors: Benjamin D. Sunkel, Benjamin Z. Stanton
• Format: Article
• Language: English
• Published: Elsevier 2021-10-01
• Series: iScience
• Subjects: Cancer systems biology; Epigenetics; Molecular biology; Systems biology
• Online Access: http://www.sciencedirect.com/science/article/pii/S2589004221011007

Summary: Transcription factors (TFs) are essential mediators of epigenetic regulation and modifiers of penetrance. Studies from the past decades have revealed a sub-class of TF that is capable of remodeling closed chromatin states through targeting nucleosomal motifs. This pioneer factor (PF) class of chromatin remodeler is ATP independent in its roles in epigenetic initiation, with nucleosome-motif recognition and association with repressive chromatin regions. Increasing evidence suggests that the fundamental properties of PFs can be coopted in human cancers. We explore the role of PFs in the larger context of tissue-specific epigenetic regulation. Moreover, we highlight an emerging class of chimeric PF derived from translocation partners in human disease and PFs associated with rare tumors. In the age of site-directed genome editing and targeted protein degradation, increasing our understanding of PFs will provide access to next-generation therapy for human disease driven from altered transcriptional circuitry.